EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Diagnosis and Management of Alzheimer’s Disease in Primary Care: A Real-World Study in Ontario, Canada

Zahinoor Ismail, Melanie Wilson, Hany Khalifa iD, Daniela Belovich, Eileen Shaw, Tram Pham, Suzanne McMullen, Yuhao Chen, Nafiz Sadman, Jackson Cai, Farhana Zulkernine, David Barber

Journal of Primary Care & Community Health · 2025

DOI: 10.1177/21501319251363156 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Zahinoor Ismail und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Psychiatry, Clinical Neurosciences, Community Health Sciences, and Laboratory Medicine and Pathology; Hotchkiss Brain Institute and O'…. Hauptthemen laut MEDLINE: Alzheimer Disease, Primary Health Care, Practice Patterns, Physicians'. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Roche Canada, f. hoffmann-la roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To understand the real-world clinical practice patterns and variation in Alzheimer’s disease (AD) diagnostic and screening tool utilization by primary care physicians (PCPs), including tools used for assessing dementia/AD severity and subsequent treatment patterns.

Methods

This retrospective observational study used de-identified primary care data from electronic medical records (EMR) data provided by the researchers from Queen’s University, Ontario, Canada from August 2011 to August 2021. Individuals ≥50 years old with dementia or AD were identified using AD and dementia-related diagnostic codes, medications, and keywords searched using natural language processing (NLP) and Artificial Intelligence (AI) algorithms from EMR chart notes. Diagnostic and screening tools included scales, neuroimaging, and laboratory tests. Medications examined were cholinesterase inhibitors, memantine, antidepressants, and antipsychotics.

Results

The study cohort included 417 individuals with all-cause dementia (mean [standard deviation: SD] age: 78.86 [0.19] years), and 71 individuals with AD (mean [SD] age: 76.13 [1.07]). The most-used scale was the Montreal Cognitive Assessment (MoCA; dementia: 53.2%, AD: 84.5%). The mean [SD] frequency of MoCA administration doubled in the year following AD index date compared to the year prior (0.29 [0.82] to 0.67 [1.19] times per patient-year). Severity scores, often unspecified, suggested various stages of cognitive impairment. Among the medications examined, cholinesterase inhibitors were prescribed in 27.8% (n = 116) and 57.8% (n = 41) of people with dementia and AD, respectively. Antidepressants were the most frequently prescribed medication examined (dementia: 49.6%; AD: 71.8%).

Conclusion

PCPs play an important role in the early detection and management of dementia/AD. As new biomarkers and therapies emerge for early AD, there is a need for connected health system data to guide PCPs through the early diagnostic process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePrimary Health CarePractice Patterns, Physicians'HumansFemaleRetrospective StudiesMaleOntarioAgedAged, 80 and overCholinesterase InhibitorsMiddle AgedElectronic Health RecordsAntidepressive AgentsAntipsychotic Agents

Stichwörter der Autor:innen

Alzheimer’s diseasedementiadiagnosisgeriatricsprimary care

Substanzen

Cholinesterase InhibitorsAntidepressive AgentsAntipsychotic Agents

Autor:innen und Institutionen

  • Departments of Psychiatry, Clinical Neurosciences, Community Health Sciences, and Laboratory Medicine and Pathology; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, AB,…
  • NIHR Exeter Biomedical Research Centre, University of Exeter, UK.
  • Hoffmann-La Roche Ltd., Mississauga, ON, Canada.
  • Medlior Health Outcomes Research Ltd., Calgary, AB, Canada.
  • Queen's University, Kingston, ON, Canada.

ORCID-Profile: Hany Khalifa

Förderung

  • Roche Canada
  • f. hoffmann-la roche

Zitieren

APA

Ismail, Z., Wilson, M., Khalifa, H., Belovich, D., Shaw, E., Pham, T., McMullen, S., Chen, Y., Sadman, N., Cai, J., Zulkernine, F., & Barber, D. (2025). Diagnosis and Management of Alzheimer’s Disease in Primary Care: A Real-World Study in Ontario, Canada. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251363156

Vancouver

Ismail Z, Wilson M, Khalifa H, Belovich D, Shaw E, Pham T, et al. Diagnosis and Management of Alzheimer’s Disease in Primary Care: A Real-World Study in Ontario, Canada. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251363156

BibTeX
@article{Ismail2025,
  author = {Ismail, Zahinoor and Wilson, Melanie and Khalifa, Hany and Belovich, Daniela and Shaw, Eileen and Pham, Tram and McMullen, Suzanne and Chen, Yuhao and Sadman, Nafiz and Cai, Jackson and Zulkernine, Farhana and Barber, David},
  title = {Diagnosis and Management of Alzheimer’s Disease in Primary Care: A Real-World Study in Ontario, Canada},
  journal = {Journal of Primary Care & Community Health},
  year = {2025},
  doi = {10.1177/21501319251363156}
}
Kostenlos starten →